Thaci D, Pinter A, Sebastian M, Termeer C, et al. Guselkumab demonstrates long-term efficacy and maintenance of treatment response
postwithdrawal in systemic treatment-naive patients and nonresponders to fumaric
acid esters: results from parts II and III of a randomized
active-comparator-controlled p Br J Dermatol 2024;191:36-48.
PMID: 38133615
|